Navigation Links
News from the Latest Issue of Molecular Medicine
Date:9/21/2009

Vitamin D and Progesterone Partner Up Against Traumatic Brain Injury

(Vocus) September 21, 2009 -- In the current issue of Molecular Medicine, a team of scientists from Emory University (Atlanta, Georgia, U.S.A.), present evidence that vitamin D and progesterone may be beneficial in protecting the brain after traumatic injury. Traumatic brain injury is a complex illness and complication after the initial injury can last months or even years. Treatments with single drugs have not met with great success in clinical trials. Previous evidence shows that vitamin D and progesterone may each be neuroprotective on their own. In this study, Dr. Fahim Atif and colleagues researched whether or not combining vitamin D and progesterone treatments would be more beneficial than either drug alone. Their results show that vitamin D is a good partner for progesterone and should be studied further pre-clinically. In addition to helping patients with traumatic brain injury, such treatment combinations may also be helpful in other injuries of the central nervous system, such as stroke.

In another intriguing study in the current issue, Japanese scientists tested whether or not stem cells, known for their ability to become any one of a number of specific kinds of cells, could be used to reduce the spread of tumors in the lung. In laboratory experiments, scientists infused stem cells into the lungs and followed up with screenings to determine if tumor spread had been slowed and if survival had been affected. On both counts, the stem cells worked to stop the growth of new cancers and to prolong survival. Importantly, the stem cell treatment did not cause inflammation as a side-effect, which bodes well for the future testing of this promising approach in patients.

In other studies, scientists mapped out the metabolic consequences of burns, an important
contribution to a common injury. You can view all of the articles in the September-October issue by visiting the journal's Web site at www.molmed.org.

Molecular Medicine is published by The Feinstein Institute for Medical Research. The peer-reviewed journal strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. The journal, a bimonthly publication, serves as a forum through which scientists and researchers can communicate recent discoveries to a multi-disciplinary, international audience interested in understanding and curing disease.

To listen to the latest podcast on these studies visit www.molmed.org/podcast.html.

Contact:
Veronica J Davis
Communications Editor
516-562-2670

###

Read the full story at http://www.prweb.com/releases/Molecular_Medicine/Traumatic_Brain_Injury/prweb2918094.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. T-System Updates Free Clinician H1N1 Templates to Latest CDC Guidelines, Adds Discharge Instructions
2. Oxygen Biotherapeutics, Inc. Posts Latest Blog by CEO Chris Stern
3. Los Angeles Clinic (laserandveinclinic.com) Offers the Latest Laser Skin Rejuvenation Treatments
4. Latest Holiday Migraine Survey Results Published
5. Nephrologists Indicate High Interest in AMAG Pharmaceuticals Newly Approved Feraheme According to Latest BioTrends Report
6. New Kodak Training Facility Showcases the Latest in Dental Technology, Solutions from Advanced Automation: Networking Solutions, Dental Practice Management and Dental X-Ray Integration
7. Veracord Delivers FDA Expertise with SyberWorks Latest Learning Management Solution
8. Neusoft Medicals Latest Innovation, NeuViz 16 CT Scanner, Approved by FDA for the U.S. Market
9. St. John's Hospital Acquires Latest Technology in Robotic-Assisted Surgery
10. GetWellNetwork Introduces Discharge Planning Tools in Latest Version of PatientLife System
11. Zenger Folkman Releases Latest Book: The Inspiring Leader: Unlocking the Secrets of How Extraordinary Leaders Motivate
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
News from the Latest Issue of Molecular Medicine 
(Date:12/5/2016)... ... December 05, 2016 , ... Sideline Products is a Southern York County ... the smaller rider and the horse. Smaller saddles can pinch and irritate the horse ... fit over a properly fitted western saddle so it does not impact the comfort ...
(Date:12/5/2016)... ... ... “Life Will Never Be The Same” is a fictional tale about growing up with ... is the creation of published author, Kim T. Briggs, a self-described “big kid” who ... religion and philosophy from Judson University in Elgin, Illinois. Having written numerous Christian drama ...
(Date:12/5/2016)... ... , ... Sabah Shah MD, MBA has joined the Retina Group of New York ... by James M. Maisel, MD and has been providing tertiary medical and surgical retinal care ... of surpassing expectations amongst her peers. Growing up in a family of doctors, Dr. ...
(Date:12/5/2016)... Greifensee, Switzerland (PRWEB) , ... ... ... testing between professional calibrations is an excellent way to ensure moisture measurements ... methods are time-consuming and impractical. , Now, METTLER TOLEDO offers a ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with ... , Over the last 60 years, studies have shown that single electrode ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... December 5, 2016 BioLineRx Ltd. (NASDAQ/TASE: ... developing promising therapeutic candidates, presents positive Phase 2a correlative data, ... leading oncology platform at the ongoing 58th American Society of ... Diego, California . ... , , As ...
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 ... alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic Response ... and tolerability profile of ropeginterferon alfa-2b versus HU ... ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing authorization ... present this data to the FDA as it seeks approval ...
(Date:12/4/2016)... 3, 2016   Pairnomix, LLC, a genetic research ... recognized by the White House, today announced that findings from ... identification of candidate therapies for a patient with epileptic encephalopathy ... were presented at the 70 th Annual Meeting of ... TX , December 2-6, 2016.  Pairnomix, unique ...
Breaking Medicine Technology: